Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · IEX Real-Time Price · USD
1.290
-0.100 (-7.19%)
At close: May 6, 2024, 4:00 PM
1.340
+0.050 (3.88%)
Pre-market: May 7, 2024, 8:03 AM EDT
IKT's stock price has decreased by -65.87% in the past year and price targets may not have had time to catch up.

Inhibikase Therapeutics Analyst Ratings

Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$27.00
Upside
+1,993.02%

Ratings History

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$27
Strong Buy Reiterates $27 +1,993.02% Mar 7, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$27
Strong Buy Maintains $27 +1,993.02% Mar 5, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$27
Strong Buy Reiterates $27 +1,993.02% Aug 15, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$5$27
Strong Buy Maintains $5$27 +1,993.02% Jun 30, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$30
Strong Buy Reiterates $30 +2,225.58% Jun 22, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +2,225.58% Apr 18, 2023
JonesTrading
JonesTrading
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Nov 16, 2022
JonesTrading
JonesTrading
Strong Buy
Initiates
n/a
Strong Buy Initiates n/a n/a Jul 15, 2021